ArticleArchives of rheumatology2018

Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis.

Yukio Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.